|
Volumn 9, Issue 2, 2013, Pages 74-76
|
The coming of age of musculoskeletal tissue engineering
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 CHLORO 5 NITROBENZANILIDE;
ALENDRONATE LLP2A CONJUGATE;
ALENDRONIC ACID;
ALGINIC ACID;
POLYACRYLAMIDE;
UNCLASSIFIED DRUG;
TISSUE SCAFFOLD;
BONE DISEASE;
BONE MATRIX;
CELL DIFFERENTIATION;
CELL MIGRATION;
CLINICAL EFFECTIVENESS;
COVALENT BOND;
CROSS LINKING;
DISEASE ASSOCIATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
EXPERIMENTAL DESIGN;
EXTRACELLULAR MATRIX;
FRACTURE;
HUMAN;
HYDROGEL;
MEDICAL DECISION MAKING;
MESENCHYMAL STEM CELL;
MESENCHYMAL STEM CELL TRANSPLANTATION;
MOLECULAR DYNAMICS;
MUSCULOSKELETAL DISEASE;
NONHUMAN;
OSSIFICATION;
OSTEOLYSIS;
OSTEOPOROSIS;
PRIORITY JOURNAL;
REGENERATIVE MEDICINE;
REVIEW;
STEM CELL TRANSPLANTATION;
TISSUE ENGINEERING;
ANIMAL;
DISEASE MODEL;
MESENCHYMAL STROMA CELL;
METHODOLOGY;
MOUSE;
PHYSIOLOGY;
ANIMALS;
DISEASE MODELS, ANIMAL;
EXTRACELLULAR MATRIX;
HUMANS;
HYDROGELS;
MESENCHYMAL STROMAL CELLS;
MICE;
MUSCULOSKELETAL DISEASES;
REGENERATIVE MEDICINE;
TISSUE ENGINEERING;
TISSUE SCAFFOLDS;
|
EID: 84873407859
PISSN: 17594790
EISSN: 17594804
Source Type: Journal
DOI: 10.1038/nrrheum.2012.235 Document Type: Review |
Times cited : (23)
|
References (10)
|